Dr Garet Jefferson Zaugg, DO | |
2020 Wellness Way Ste 300, Las Vegas, NV 89106-4145 | |
(702) 432-2233 | |
(702) 800-5456 |
Full Name | Dr Garet Jefferson Zaugg |
---|---|
Gender | Male |
Speciality | Neurology |
Experience | 8 Years |
Location | 2020 Wellness Way Ste 300, Las Vegas, Nevada |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003264151 | NPI | - | NPPES |
100547355 | Medicaid | NV |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084N0400X | Psychiatry & Neurology - Neurology | DO2675 (Nevada) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Centennial Hills Hospital Medical Center | Las vegas, NV | Hospital |
Spring Valley Hospital Medical Center | Las vegas, NV | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Janda Mahajan And Balsiger Pllc | 7315257797 | 23 |
News Archive
Xhale Innovations, a leading provider of patient safety technology, announced today the results of a study presented by Miami Children's Hospital at the Annual Society for Healthcare Epidemiology of America Conference on the HyGreen Hand Hygiene Reminder System.
"Former President Bill Clinton delivered an energizing 'call to action' at the closing session of [the XIX International AIDS Conference (AIDS 2012)], encapsulating the high hopes and the sobering challenges facing the fight against global HIV/AIDS," Janet Fleischman, a senior associate at the Center for Strategic & International Studies' (CSIS) Global Health Policy Center, writes in the center's "Smart Global Health" blog.
A consortium of 48 scientists from 50 institutions in the United States - including Pamela Silver, Ph.D., a Core Faculty member at the Wyss Institute for Biologically Inspired Engineering at Harvard University - are calling for a Unified Microbiome Initiative that would span national cross-institutional and cross-governmental agency support.
A new study using data from over 5,000 individuals has found that a measure of belly fat (waist:hip ratio) was associated with reduced cognitive function in older Irish adults (>60 years of age).
Forbius, a clinical stage company developing biotherapeutics targeting EGFR and TGF-β pathways, today announced that the first patient has been dosed in a Phase 2a trial evaluating the efficacy and safety of AVID100 in patients with squamous non-small cell lung cancer whose tumors overexpress epidermal growth factor receptor.
› Verified 1 days ago
Entity Name | Janda Mahajan & Balsiger Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457731242 PECOS PAC ID: 7315257797 Enrollment ID: O20151116000744 |
News Archive
Xhale Innovations, a leading provider of patient safety technology, announced today the results of a study presented by Miami Children's Hospital at the Annual Society for Healthcare Epidemiology of America Conference on the HyGreen Hand Hygiene Reminder System.
"Former President Bill Clinton delivered an energizing 'call to action' at the closing session of [the XIX International AIDS Conference (AIDS 2012)], encapsulating the high hopes and the sobering challenges facing the fight against global HIV/AIDS," Janet Fleischman, a senior associate at the Center for Strategic & International Studies' (CSIS) Global Health Policy Center, writes in the center's "Smart Global Health" blog.
A consortium of 48 scientists from 50 institutions in the United States - including Pamela Silver, Ph.D., a Core Faculty member at the Wyss Institute for Biologically Inspired Engineering at Harvard University - are calling for a Unified Microbiome Initiative that would span national cross-institutional and cross-governmental agency support.
A new study using data from over 5,000 individuals has found that a measure of belly fat (waist:hip ratio) was associated with reduced cognitive function in older Irish adults (>60 years of age).
Forbius, a clinical stage company developing biotherapeutics targeting EGFR and TGF-β pathways, today announced that the first patient has been dosed in a Phase 2a trial evaluating the efficacy and safety of AVID100 in patients with squamous non-small cell lung cancer whose tumors overexpress epidermal growth factor receptor.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Garet Jefferson Zaugg, DO 1930 Village Center Cir Ste 3-717, Las Vegas, NV 89134-6299 Ph: (702) 432-2233 | Dr Garet Jefferson Zaugg, DO 2020 Wellness Way Ste 300, Las Vegas, NV 89106-4145 Ph: (702) 432-2233 |
News Archive
Xhale Innovations, a leading provider of patient safety technology, announced today the results of a study presented by Miami Children's Hospital at the Annual Society for Healthcare Epidemiology of America Conference on the HyGreen Hand Hygiene Reminder System.
"Former President Bill Clinton delivered an energizing 'call to action' at the closing session of [the XIX International AIDS Conference (AIDS 2012)], encapsulating the high hopes and the sobering challenges facing the fight against global HIV/AIDS," Janet Fleischman, a senior associate at the Center for Strategic & International Studies' (CSIS) Global Health Policy Center, writes in the center's "Smart Global Health" blog.
A consortium of 48 scientists from 50 institutions in the United States - including Pamela Silver, Ph.D., a Core Faculty member at the Wyss Institute for Biologically Inspired Engineering at Harvard University - are calling for a Unified Microbiome Initiative that would span national cross-institutional and cross-governmental agency support.
A new study using data from over 5,000 individuals has found that a measure of belly fat (waist:hip ratio) was associated with reduced cognitive function in older Irish adults (>60 years of age).
Forbius, a clinical stage company developing biotherapeutics targeting EGFR and TGF-β pathways, today announced that the first patient has been dosed in a Phase 2a trial evaluating the efficacy and safety of AVID100 in patients with squamous non-small cell lung cancer whose tumors overexpress epidermal growth factor receptor.
› Verified 1 days ago
Dr. Ejine Okoroafor, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5440 W Sahara Ave, Suite 202, Las Vegas, NV 89146 Phone: 914-426-7774 | |
Dr. Muhammed A Hyder, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2465 E Twain Ave, Las Vegas, NV 89121 Phone: 702-789-6201 Fax: 304-522-0686 | |
Dr. Krista Linn Pinard, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3016 W Charleston Blvd Ste 150, Las Vegas, NV 89102 Phone: 702-790-2701 | |
Gobinder S. Chopra, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 6410 Medical Center St Ste A100, Las Vegas, NV 89148 Phone: 702-796-8500 Fax: 702-796-8502 | |
Eden Santiago Lee, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3014 W Charleston Blvd Ste 130, Las Vegas, NV 89102 Phone: 702-671-6475 Fax: 702-671-6440 | |
John Reitano, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 501 S Rancho Dr, Ste I62, Las Vegas, NV 89106 Phone: 702-897-7250 Fax: 702-706-4838 |